Their results demonstrate that the ERK/MAPK pathway is suppressed as a result of reduced levels of lncRNA MALAT1 in Sprague-Dawley rats, leading to a significant improvement in heart function after MI (32). The gene discussed is MAPK1; the disease is myocardial infarction.